The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy

被引:3
作者
Berwald, Grace [1 ]
Young, Graeme P. [2 ]
Cock, Charles [3 ]
Bampton, Peter [2 ]
Fraser, Robert [3 ]
Symonds, Erin L. [3 ,4 ]
机构
[1] Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Med, Bedford Pk, SA, Australia
[2] Flinders Hlth & Med Res Inst, Canc Res, Bedford Pk, SA, Australia
[3] Southern Adelaide Local Hlth Network, Flinders Med Ctr, Dept Gastroenterol & Hepatol, Bedford Pk, SA, Australia
[4] Flinders Ctr Innovat Canc, Level 3,Flinders Dr, Bedford Pk, SA 5042, Australia
关键词
Fecal Immunochemical Test; Colonoscopy; Surveillance; Colorectal Neoplasia; COLORECTAL-CANCER; HYPERPLASTIC POLYPS; SERRATED ADENOMAS; RISK-FACTORS;
D O I
10.1016/j.cgh.2023.09.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: An increasing burden on health care resources has resulted in a backlog of individuals requiring colonoscopy, with delays in surveillance possibly detrimental for individuals at increased risk of colorectal cancer (CRC). This study investigated the use of a 2 -sample fecal immunochemical test (FIT) to establish those most likely to have advanced neoplasia (AN) and in need of prioritized surveillance colonoscopy. METHODS: This was a prospective study conducted in the tertiary care setting. Participants completed a 2sample FIT (OC-Sensor, Eiken Chemical Company) within 90 days of surveillance colonoscopy. The sensitivity of FIT for detection of AN (CRC or advanced adenoma) in moderate- and highrisk individuals was determined at fecal hemoglobin thresholds between 2 and 80 mu g/g feces. RESULTS: A total of 766 patients were included (median age, 66.1 years [interquartile range, 58.1 - 72.9]; 49.9% male), with AN detected in 8.6% (66/766, including 5 CRC). For moderate -risk individuals (with prior history of adenoma or a signi fi cant family history of CRC), sensitivity of FIT for AN ranged from 73.5% at 2 mu g/g feces, to 10.2% at 80 mu g/g feces. For high -risk conditions (con fi rmed/suspected genetic syndromes or prior CRC), sensitivity of FIT was similar, ranging from 70.6% at the lowest positivity threshold of 2 mu g/g feces, to 11.8% at 80 mu g/g feces. Independent variables in the whole cohort for association with detection of AN at surveillance colonoscopy were age (odds ratio, 1.03; 95% con fi dence interval, 1.00 - 1.06) and FIT hemoglobin result double dagger 10 mu g/g feces (odds ratio, 1.81; 95% con fi dence interval, 1.04 - 3.16). CONCLUSIONS: The use of FIT before surveillance colonoscopy provides clinicians with insights into the risk of AN. This raises the possibility of a method to triage individuals, facilitating the more ef fi cient management of endoscopic resources.
引用
收藏
页码:878 / 885.e2
页数:10
相关论文
共 28 条
  • [1] Surveillance Colonoscopy in Elderly Patients A Retrospective Cohort Study
    An Hong Tran
    Ngor, Eunis Wai Man
    Wu, Bechien U.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1675 - 1682
  • [2] Serrated Polyp Detection by the Fecal Immunochemical Test: An Imperfect FIT
    Anderson, Joseph C.
    Robertson, Douglas J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 880 - 882
  • [3] Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study
    Atkin, Wendy
    Wooldrage, Kate
    Brenner, Amy
    Martin, Jessica
    Shah, Urvi
    Perera, Sajith
    Lucas, Fiona
    Brown, Jeremy P.
    Kralj-Hans, Ines
    Greliak, Paul
    Pack, Kevin
    Wood, Jill
    Thomson, Ann
    Veitch, Andrew
    Duffy, Stephen W.
    Cross, Amanda J.
    [J]. LANCET ONCOLOGY, 2017, 18 (06) : 823 - 834
  • [4] Applying evidence-based guidelines improves use of colonoscopy resources in patients with a moderate risk of colorectal neoplasia
    Bampton, PA
    Sandford, JJ
    Young, GP
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (04) : 155 - 157
  • [5] Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program
    Buron, Andrea
    Roman, Marta
    Auge, Josep M.
    Macia, Francesc
    Grau, Jaume
    Sala, Maria
    Louro, Javier
    Martinez-Alonso, Montserrat
    Alvarez-Urturi, Cristina
    Andreu, Montserrat
    Bessa, Xavier
    Zaffalon, Diana
    Castells, Antoni
    Pellise, Maria
    Aldea, Marta
    Rivero, Liseth
    Hernandez, Cristina
    Tora-Rocamora, Isabel
    Castells, Xavier
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 107 : 53 - 59
  • [6] Cancer Council Australia, 2017, Colorectal Cancer Guidelines Working Party. Risk and screening based on family history of colorectal cancer in clinical practice guidelines for the prevention, early detection and management of colorectal cancer
  • [7] Cancer Council Australia Colonoscopy Surveillance Working Party, 2011, CLIN PRACTICE GUIDEL
  • [8] Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity
    Chang, Li-Chun
    Shun, Chia-Tung
    Hsu, Weng-Feng
    Tu, Chia-Hong
    Tsai, Pei-Yu
    Lin, Been-Ren
    Liang, Jin-Tung
    Wu, Ming-Shiang
    Chiu, Han-Mo
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (06) : 872 - +
  • [9] Low Sensitivity of Fecal Immunochemical Tests and Blood-Based Markers of DNA Hypermethylation for Detection of Sessile Serrated Adenomas/Polyps
    Cock, Charles
    Anwar, Shahzaib
    Byrne, Susan E.
    Meng, Rosie
    Pedersen, Susanne
    Fraser, Robert J. L.
    Young, Graeme P.
    Symonds, Erin L.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (09) : 2555 - 2562
  • [10] Faecal haemoglobin concentration is related to severity of colorectal neoplasia
    Digby, Jayne
    Fraser, Callum G.
    Carey, Francis A.
    McDonald, Paula J.
    Strachan, Judith A.
    Diament, Robert H.
    Balsitis, Margaret
    Steele, Robert J. C.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (05) : 415 - 419